2.9107
前日終値:
$2.84
開ける:
$2.86
24時間の取引高:
152.07K
Relative Volume:
0.24
時価総額:
$77.79M
収益:
$59.07M
当期純損益:
$-52.66M
株価収益率:
-1.4481
EPS:
-2.01
ネットキャッシュフロー:
$-40.16M
1週間 パフォーマンス:
-5.84%
1か月 パフォーマンス:
-41.65%
6か月 パフォーマンス:
-52.54%
1年 パフォーマンス:
-61.69%
Cvrx Inc Stock (CVRX) Company Profile
Compare CVRX vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CVRX
Cvrx Inc
|
2.92 | 75.13M | 59.07M | -52.66M | -40.16M | -2.01 |
|
ABT
Abbott Laboratories
|
115.65 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
329.56 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.54 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.84 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.89 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-01-14 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-07-11 | 繰り返されました | Lake Street | Buy |
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2024-05-01 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-05-01 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 開始されました | Lake Street | Buy |
| 2022-07-18 | 開始されました | Craig Hallum | Buy |
| 2021-07-26 | 開始されました | Canaccord Genuity | Buy |
| 2021-07-26 | 開始されました | Piper Sandler | Overweight |
| 2021-07-26 | 開始されました | William Blair | Outperform |
すべてを表示
Cvrx Inc (CVRX) 最新ニュース
Investigation launched into CVRx over DOJ probe, sales issues, and sudden CRO firing - Pluang
HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
CVRx (CVRX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Eastern Progress
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CVRx, Inc. (CVRX) And Encourages Investors to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Law firm investigates CVRx for possible securit... - Pluang
Cantor Fitzgerald Maintains CVRx Inc(CVRX.US) With Buy Rating, Cuts Target Price to $5 - Moomoo
CVRX Q2 2026 Earnings: Modest EPS Beat Offset by 10.71% Share SlidePositive Surprise Momentum - Vinanet
Cantor cuts CVRx stock price target on sales execution challenges - Investing.com
Cantor cuts CVRx stock price target on sales execution challenges By Investing.com - Investing.com India
Cantor Fitzgerald Issues Pessimistic Forecast for CVRx (NASDAQ:CVRX) Stock Price - MarketBeat
Johnson & Johnson Invests $20.69 Billion in CVRx, Inc. $CVRX - MarketBeat
CVRX Q2 2026 Earnings: Narrower-Than-Expected Loss Fuels 4.76% Stock GainDividend Increase Stocks - Vinanet
CVRx, Inc. (CVRX) investor Jorey Chernett discloses 5.5% beneficial stake - Stock Titan
Cvrx COO Brent Binkowski sells $3,338 in company stock By Investing.com - Investing.com South Africa
Cvrx COO Brent Binkowski sells $3,338 in company stock - Investing.com
Cvrx COO Brent Binkowski buys $76,432 in company stock By Investing.com - Investing.com Australia
CVRx (NASDAQ:CVRX) COO Brent Binkowski Buys 26,223 Shares of Stock - MarketBeat
Cvrx COO Brent Binkowski buys $76,432 in company stock - Investing.com
CVRx (CVRX) COO Brent Binkowski purchases 26,223 shares in open-market buy - Stock Titan
Insider Purchase: CHIEF OPERATING OFFICER of $CVRX Buys 26,223 Shares - Moomoo
CVRx (CVRX) Q2 2026 Earnings Call Transcript - AOL.com
HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages - GlobeNewswire
CVRx (CVRX) COO executes 1,309-share sell-to-cover under Rule 10b5-1 plan - Stock Titan
Block & Leviton investigates CVRx for possible securities law violations after revenue guidance cut. - Pluang
CVRx Eyes Barostim Growth as Coverage Gains and BENEFIT-HF Trial Launches - MarketBeat
CCORF Maintains CVRx Inc(CVRX.US) With Buy Rating, Cuts Target Price to $5 - Moomoo
CVRx chief revenue officer exits amid slowing sales and execution concerns - The Business Journals
CVRx replaces chief revenue officer amid sales transition - The Globe and Mail
CVRx at Canaccord Genuity growth conference: reimbursement gains, sales strain - Investing.com UK
CVRx, Inc. $CVRX Shares Acquired by Royal Bank of Canada - MarketBeat
CVRx names interim sales head as revenue officer departs By Investing.com - Investing.com Australia
Form 8K CVRx Inc For: 11 August By Investing.com - Investing.com UK
CVRx to replace CRO after cutting guidance and DOJ civil inquiry - MassDevice
CVRx, Inc. Investors With Losses Should Contact Block & Leviton About Securities Fraud Investigation - The National Law Review
CVRx, Inc. (CVRX) Presents at Canaccord Genuity's 46th Annual Growth ConferenceSlideshow - Seeking Alpha
CVRX: Execution improvements and payer wins position the therapy for broader adoption and growth - TradingView
CVRx Inc (CVRX) Stock News Today - TradingKey
Craig-Hallum Downgrades CVRx Inc(CVRX.US) to Hold Rating - Moomoo
CVRx names interim sales head as revenue officer departs - Investing.com
CVRx Announces Sales Leadership Transition - The Manila Times
CV's Robert John departs as Chief Revenue Officer - tradingview.com
CVRx, Inc. Announces Executive Changes, Effective August 11, 2026 - marketscreener.com
CVRx Inc(CVRX) Stock Options Chain | Quotes & News - moomoo.com
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - WBOC TV
CVRX INVESTIGATION: CVRx, Inc. Investigated for Securities Fraud by Block & Leviton; ... - Caledonian Record
Cvrx Inc (CVRX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):